Clinical trial
EASE Trial: Exhale Airway Stents for Emphysema
NCT00391612 · Broncus Technologies, Industry · Unknown status
Key facts
| NCT number | NCT00391612 |
|---|---|
| Title | EASE Trial: Exhale Airway Stents for Emphysema |
| Official title | A Randomized, Double-blind Study to Evaluate the Safety and Effectiveness of the Exhale® Drug-Eluting Stent in Homogeneous Emphysema Subjects With Severe Hyperinflation |
| Acronym | EASE |
| Lead sponsor | Broncus Technologies, Industry |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Emphysema |
| Intervention type | Device |
| Interventions | Exhale® Drug-Eluting Stent, Sham control |
| Enrollment | 450 |
| Start date | May 1, 2006 |
| Primary completion | Oct 1, 2009 |
| Completion | Dec 1, 2013 |
| First posted | Oct 24, 2006 |
| Last update posted | Jan 12, 2011 |
| Countries | Australia, Austria, Brazil, Canada, Germany, Ireland, Netherlands, Spain, United Kingdom, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: